EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
Open Access
- 1 August 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (15) , 5145-5150
- https://doi.org/10.1158/1078-0432.ccr-03-0589
Abstract
Purpose: EphA2 (epithelial cell kinase) is a transmembrane receptor tyrosine kinase that has been implicated in oncogenesis. There are no published data regarding the role of EphA2 in ovarian carcinoma, which is the focus of the present study.Keywords
This publication has 43 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinomaInternational Journal of Cancer, 2002
- Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascadeOncogene, 2002
- Importance of Vascular Phenotype by Basic Fibroblast Growth Factor, and Influence of the Angiogenic Factors Basic Fibroblast Growth Factor/Fibroblast Growth Factor Receptor-1 and Ephrin-A1/EphA2 on Melanoma ProgressionThe American Journal of Pathology, 2002
- Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosisOncogene, 2001
- Molecular Determinants of Ovarian Cancer PlasticityThe American Journal of Pathology, 2001
- The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularizationOncogene, 2000
- THE EPHRINS AND EPH RECEPTORS IN NEURAL DEVELOPMENTAnnual Review of Neuroscience, 1998
- ECK,a HumanEPH-Related Gene, Maps to 1p36.1, a Common Region of Alteration in Human CancersGenomics, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996